Oramed Pharmaceuticals Inc. Common Stock (ORMP)
Stock · NASDAQ · Health Care
$4.05as of 10/16/2026
Price chart
Active signals
ORMP Signal Track Record
How signals performed across all stocks →What ORMP's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | +3.1% | 53% | September 18, 2026 |
| Bollinger Band Breakout | 27 | -2.0% | 41% | August 25, 2026 |
| 200-Day Moving Average TouchActive now | 18 | -3.2% | 28% | November 5, 2025 |
| Bollinger Band Breakdown | 15 | +3.5% | 60% | October 1, 2026 |
| Any 20-session window (baseline) | +0.9% | 52% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ORMP
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharm…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- oramed.com/
Fundamentals
- 1-day range
- $3.99$4.19
- Market cap
- $178.87M
- P/E (trailing)
- 0.98
- P/E (forward)
- -50.13
- EPS (trailing)
- $4.13
- Dividend yield
- 5.22%
- Beta
- 1.27
- Avg. volume
- 186.8K
- Ex-dividend date
- January 16, 2026
- Dividend pay date
- January 26, 2026
How Oramed Pharmaceuticals Inc. Common Stock Makes Money
Where the revenue actually goes — FY2022 annual results
Source: 10-K filed Mar 6, 2023 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Oramed Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ORMPOramed Pharmaceuticals Inc. Common Stock$4.07▼ 2.63%Market cap $178.87MP/E 0.98$2.09$5.47
- DERMJourney Medical Corporation Common Stock$4.97▼ 3.12%Market cap $179.80MP/E —$4.31$9.56
- CRBPCorbus Pharmaceuticals Holdings Inc. Common Stock$4.52▲ 4.39%Market cap $180.46MP/E —$4.23$20.56
- LFCRLifecore Biomedical Inc. Common Stock$6.38▼ 0.93%Market cap $181.55MP/E —$3.63$8.98
- KRROKorro Bio Inc. Common Stock$8.49▼ 8.81%Market cap $174.80MP/E —$5.2$55.89
- ARCTArcturus Therapeutics Holdings Inc. Common Stock$10.34▼ 8.25%Market cap $172.81MP/E —$5.5$24.17
- TNXPTonix Pharmaceuticals Holding Corp. Common Stock$6.04▼ 5.92%Market cap $185.71MP/E —$6.01$20.69
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ORMP Oramed Pharmaceuticals Inc. Common Stock | $178.87M | 0.98 | $4.07 | ▼ 2.63% | $2.09$5.47 |
| DERM Journey Medical Corporation Common Stock | $179.80M | — | $4.97 | ▼ 3.12% | $4.31$9.56 |
| CRBP Corbus Pharmaceuticals Holdings Inc. Common Stock | $180.46M | — | $4.52 | ▲ 4.39% | $4.23$20.56 |
| LFCR Lifecore Biomedical Inc. Common Stock | $181.55M | — | $6.38 | ▼ 0.93% | $3.63$8.98 |
| KRRO Korro Bio Inc. Common Stock | $174.80M | — | $8.49 | ▼ 8.81% | $5.2$55.89 |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | $172.81M | — | $10.34 | ▼ 8.25% | $5.5$24.17 |
| TNXP Tonix Pharmaceuticals Holding Corp. Common Stock | $185.71M | — | $6.04 | ▼ 5.92% | $6.01$20.69 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Joshua Hexter · July 2, 2026 · Option Exercise50.0K @ $3.69
- Joshua Hexter · July 1, 2026 · Sale137.0K @ $4.46
- Avraham Gabay · July 1, 2026 · Sale73.4K @ $4.51
Institutional Ownership
March 31, 2026
- Total shares held
- 13.23M
- Total value held
- $44.75M
- Institutional holders
- 63
- Unknown3.17M
- Unknown2.11M
- Unknown1.91M
- Unknown1.64M
- Unknown1.32M
- Unknown600.7K
- Unknown259.6K
- Unknown233.0K
- Unknown158.2K
- Unknown157.6K
See the full, filterable feed with live charts on the MarketWall dashboard.